Actively Recruiting
Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care
Led by New York University · Updated on 2026-04-13
500
Participants Needed
1
Research Sites
193 weeks
Total Duration
On this page
Sponsors
N
New York University
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study's long-term goal is to improve clinical outcomes among smokers living with HIV (SLWH) by providing smoking cessation interventions in HIV clinical care that will increase the chances of quitting smoking, limits costs and burden on staff and reach many smokers living with HIV.
CONDITIONS
Official Title
Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Status as HIV+
- Age 18 or older
- Currently smokes 65 5 cigarettes per day on average in past month
- Positive for salivary cotinine
- Able to understand the nature of the study and the consenting process
- Is engaged in HIV clinical care
- Living in larger NYC metropolitan area currently and for the next 6-8 months
You will not qualify if you...
- Has any medical condition or contraindication that prevents use of nicotine replacement therapy
- Currently using any tobacco cessation medications such as varenicline, NRT patch, nicotine gum, lozenge, spray, inhaler, or bupropion
- Currently participating in another smoking cessation program
- Pregnant or nursing and plans to be in next 6 months
- Has schizophrenia or schizo-affective disorder
- Does not have a functioning mobile phone that can receive text messages
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
New York University School of Global Public Health
New York, New York, United States, 10003
Actively Recruiting
Research Team
J
Jennifer Cantrell, DrPH, MPA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
FACTORIAL
Primary Purpose
TREATMENT
Number of Arms
16
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here